Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel

Volume: 33, Issue: 3, Pages: 850 - 858
Published: May 25, 2020
Abstract
The chemoresistance of tumors is the main barrier to cancer treatment. Interleukin-22 (IL-22) plays an important role in the chemoresistance of multi-cancers; however, the roles of IL-22 in the paclitaxel resistance of lung adenocarcinoma cells remain to be investigated. The present study aims to investigate the potential mechanisms of IL-22 enhancing the chemoresistance of lung adenocarcinoma cells to paclitaxel. We cultured A549, H358, and...
Paper Details
Title
Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel
Published Date
May 25, 2020
Journal
Volume
33
Issue
3
Pages
850 - 858
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.